25 results for “Neurotransmitter Systems”. Showing 25 of 39,449.
Medial prefrontal cortex circuit dynamics involved in stage-specific addiction.
neurotransmitter systems, neural circuits, molecules and synaptic adaptations on the regulation
Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication.
system, and neurotransmitter systems, thereby influencing brain function. Phytochemicals such
Cholinergic modulation of auditory P3 event-related potentials as indexed by CHRNA4 and CHRNA7 genotype variation in healthy volunteers.
system affect neighbouring neurotransmitter systems and contribute to neurocognitive deficits
Altered Expression of GABA-Related Genes in Schizophrenia: Insights from Meta-Analyses of Brain and Blood Samples and iPSC-Derived Organoids
neurotransmitter systems, including dopamine, serotonin, γ-aminobutyric acid (GABA), and glutamate
Parkinson's Disease and Dementia with Lewy Bodies: One and the Same.
system over other degenerating neurotransmitter systems, has once more brought
Prenatal alcohol exposure dysregulates the expression of clock genes and alters rhythmic behaviour in mice.
system (e.g. Cnr1, Dagla, Faah) and other neurotransmitter systems (e.g. Oprm1
Consequences of Disturbing Manganese Homeostasis.
systems, neurotransmitter production, and the regulation of reproductive hormones. However
Synuclein and Mitochondrial Dysfunction: Regulating the Protein Import Complex toward PD Treatment?
neurotransmitter systems also contribute to PD symptoms. α-Synuclein (αSyn
Cerebral Dopamine Neurotrophic Factor (CDNF): Structure, Functions, and Therapeutic Potential.
system in the brain. In particular, there are data on participation of CDNF in the maturation and maintenance of other neurotransmitter
Molecular mechanisms underlying obesity-induced memory dysfunction: a comprehensive narrative review.
neurotransmitter system imbalances, and central insulin resistance. Critically, obesity profoundly
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms.
neurotransmitter systems involved in PDP initiation and progression. In this
Therapeutic strategies for Alzheimer's disease in clinical trials.
neurotransmitter systems (serotoninergic 5-HT6 and histaminergic H3). Ongoing clinical
Sleep and neurological autoimmune diseases.
neurotransmitters systems (e.g., hypocretin) that regulate sleep resulting in sleep
Inflammation and depression: a causal or coincidental link to the pathophysiology?
neurotransmitter systems may be more effective antidepressants.The preliminary clinical evidence
Topographic structure and function of locus coeruleus norepinephrine neurons
neurotransmitter system and show that it contains learning signals for flexible
VEEV TC-83 Triggers Dysregulation of the Tryptophan-Kynurenine Pathway in the Central Nervous System That Correlates with Cognitive Impairment in Tg2576 Mice.
neurotransmitter systems as well as on inflammation, as observed in VEEV
Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain
Dynamic coupling of whole-brain neuronal and neurotransmitter systems
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
neurotransmitter systems, functional networks, cytoarchitectonic classes, and cognitive brain systems
Circadian clock genes and insomnia: molecular mechanisms and therapeutic implications.
neurotransmitter systems (melatonin, serotonin, GABA, dopamine), metabolic imbalance, neuroinflammation, mitochondrial
Obestatin attenuated methamphetamine-induced PC12 cells neurotoxicity via inhibiting autophagy and apoptosis.
neurotransmitter system of the brain and is responsible for enhancing
Altered Grooming Syntax and Amphetamine-Induced Dopamine Release in EAAT3 Overexpressing Mice.
neurotransmitter system is implicated in ritualistic behaviors. Indeed, dopaminergic neurons
Alzheimer's Disease-associated Region-specific Decrease of Vesicular Glutamate Transporter Immunoreactivity inthe Medial Temporal Lobe and Superior Temporal Gyrus.
neurotransmitter system is thought to play a major role in the pathogenesis
Neurotransmitter Systems in Alzheimer’s Disease
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials.
neurotransmitter systems in schizophrenia pathophysiology, including acetylcholine, gamma-aminobutyric acid